In this study, 1,3,4-thiadiazole derivatives were obtained from the reaction of benzophenone-4,4'-dicarboxylic acid and N-substitute-thiosemicarbazide compounds with each other. After the synthesis of the final products, some biological properties of these compounds such as antibiofilm, antimicrobial and efflux pump inhibiting efficiencies were evaluated. According to the MBC/MFC test, all the activities were found to be bacteriostatic, also, especially the biofilm inhibition activity of C1 against K. pneumoniae is noteworthy. In addition, C4 was observed to exhibit efflux pump inhibition activity in E. coli, whereas C2 and C3 in K. pneumoniae. The absorption and emission values of the molecules were obtained and electrochemical studies were performed. In addition; absorption, metabolism, distribution, excretion and toxicity (ADMET) scores were predicted using the pharmacokinetic properties of all 1,3,4-thiadiazole compounds. Finally, the electrochemical stabilities of the synthesized molecules have been analyzed by using cyclic voltammetry in 0.1 M TBAPF6 in DMSO as a supporting electrolyte.
15 August 2020 in International Journal of Biology and Chemistry
Antibiotics are compounds, which inhibit the growth of or destroy microorganisms, thus are used to treat and prevent infections. But for some reason, microorganisms in time develop resistance to antibiotics. One of the reasons for resistance to antibiotics is efflux pumps. By means of these pumps, microorganisms export antibiotics entered into the bacterial cell; therefore, they cannot inhibit the growth of or destroy bacteria. This situation decreases the activity spectrum of the antibiotic and increases the antibiotic resistance. Thus, microorganisms could develop multiple drug resistance against not only the antibiotic used, but also for many other antibiotics and rapidly spread to the environment. For this reason, antibiotic resistance has become a major problem all over the world, and new antibiotics and efflux pump inhibitor studies are continuing rapidly. The aim of this study is to observe the response of some Escherichia coli clinical isolate strains with multiple drug resistance and overexpressed efflux pumps against efflux pump inhibitors, in order to use these strains for further studies. Ethidium bromide (EtBr)-agar cartwheel method was firstly used to identify E. coli strains with overexpressed efflux pumps by transferring inoculum of all strains to EtBr containing agars, and overexpressed efflux pumps were determined by exposing agar plates to UV light. Verapamil, phenyl arginine beta naphthylamide (PAβN) and thioridazine hydrochloride were used as efflux pump inhibitors (EPIs), and the lowest concentration of EPIs those inhibit the growth of E. coli strains were determined by minimal inhibition concentration (MIC) test. Lastly, the responses of microorganisms against efflux pump inhibitors were determined with a microplate based assay, by using EPIs below their MIC values. According to the results of this study; effect of verapamil and thioridazine was observed to be more effective than PAβN. As a result 98.41% of the E. coli strains used in the study was found to be affected by verapamil, where 96.82% by thioridazine and only 38.09% was affected by PAβN inhibitor.
Antibiotic resistance poses a critical threat to global health, largely driven by bacterial efflux pumps that expel antibiotics and reduce their efficacy. This study investigated the potential of Phellinus hartigii ethyl acetate extract (Ph-Ace) to inhibit efflux pumps and restore antibiotic activity against multidrug-resistant Escherichia coli strains. In vitro assays demonstrated that Ph-Ace effectively inhibited efflux pumps, enhancing the efficacy of resistant antibiotics. GC/MS analysis identified key components such as nonadecane and octacosane. These findings suggest Ph-Ace as a promising natural efflux pump inhibitor. Further molecular and clinical studies are required to confirm its therapeutic potential.